Mangoceuticals, Inc. – NASDAQ:MGRX

Add to watchlist

$1.46

-1.13

-43.84%

Market closed

Open in 3 days

+602.70%

month

+602.70%

quarter

+746.91%

year

Market Cap	4.77M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-0.47

Revenue	844.86K
EBITDA	-9.00M
Income	-9.01M
Revenue Q/Q	112.56%
Revenue Y/Y	670.43%

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	-1065.54%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Mangoceuticals, Inc. (NASDAQ:MGRX): Profit margin
Jun 2023	141.23K	-2.28M	-1617.16%
Sep 2023	245.16K	-1.79M	-733.99%
Dec 2023	244.37K	-2.56M	-1050.87%
Mar 2024	214.09K	-2.36M	-1105.86%

Mangoceuticals, Inc. (NASDAQ:MGRX): Debt to assets
Jun 2023	3296562	293.87K	8.91%
Sep 2023	1595505	240.68K	15.09%
Dec 2023	1050793	276.03K	26.27%
Mar 2024	301447	1.25M	417.96%

Mangoceuticals, Inc. (NASDAQ:MGRX): Cash Flow
Jun 2023	-1.77M	0	935.3K
Sep 2023	-1.71M	0	0
Dec 2023	-1.69M	3.51K	1.2M
Mar 2024	-991.13K	0	267.5K

Mangoceuticals alternative data

Mangoceuticals, Inc. (NASDAQ:MGRX): Employee count
Aug 2023	2
Sep 2023	2
Oct 2023	2
Nov 2023	2
Dec 2023	2
Jan 2024	2
Feb 2024	2
Mar 2024	2
Apr 2024	2
May 2024	3
Jun 2024	3
Jul 2024	3

Mangoceuticals
Insider Trading

Mangoceuticals, Inc. (NASDAQ:MGRX): Insider trades (number of shares)
Period	Buy	Sel
Jun 2024	0	125000

Transaction	Date	Insider	Security	Shares	Price per share	Total value	Source
Sale	26 Jun 2024	HAMILTON ALEX P. director director	Common Stock	108,426	$0.32	$34,696
Sale	25 Jun 2024	HAMILTON ALEX P. director director	Common Stock	16,574	$0.31	$5,138

MGRX insider trading transactions

Mangoceuticals
Latest News

Thursday, 19 December 2024
17:33	Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent	globenewswire.com
Monday, 21 October 2024
17:10	MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly	globenewswire.com
Friday, 18 October 2024
08:45	Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024	newsfilecorp.com
Friday, 11 October 2024
17:15	MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN	globenewswire.com
Thursday, 3 October 2024
08:30	MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions	globenewswire.com
Tuesday, 1 October 2024
07:30	MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment	globenewswire.com
Friday, 12 July 2024
13:30	MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department	globenewswire.com
Thursday, 11 July 2024
08:15	MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets	globenewswire.com
Thursday, 6 June 2024
08:30	MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology	globenewswire.com
Tuesday, 4 June 2024
16:00	MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies	globenewswire.com
Tuesday, 28 May 2024
08:30	Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets	globenewswire.com
Thursday, 23 May 2024
08:30	MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts	globenewswire.com
Tuesday, 21 May 2024
16:00	Why Is Mangoceuticals (MGRX) Stock Up 130% Today?	investorplace.com
08:30	MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications	globenewswire.com
Thursday, 16 May 2024
16:40	MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration	globenewswire.com
Thursday, 2 May 2024
08:00	Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement	globenewswire.com
Friday, 12 April 2024
08:45	Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products	globenewswire.com
Tuesday, 12 March 2024
09:00	MangoRx Officially Launches ‘PRIME' by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment	globenewswire.com
Tuesday, 20 February 2024
09:00	MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth	globenewswire.com
Tuesday, 6 February 2024
09:00	MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE	globenewswire.com
Monday, 5 February 2024
08:50	MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product	globenewswire.com
Friday, 15 December 2023
09:29	Why Is Mangoceuticals (MGRX) Stock Down 33% Today?	InvestorPlace

Frequently Asked Questions (FAQ)

What's the price of Mangoceuticals stock today?

One share of Mangoceuticals stock can currently be purchased for approximately $1.46.
When is Mangoceuticals's next earnings date?

Unfortunately, Mangoceuticals's (MGRX) next earnings date is currently unknown.
Does Mangoceuticals pay dividends?

No, Mangoceuticals does not pay dividends.
How much money does Mangoceuticals make?

Mangoceuticals has a market capitalization of 4.77M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8083.16% to 731.49K US dollars.
What is Mangoceuticals's stock symbol?

Mangoceuticals, Inc. is traded on the NASDAQ under the ticker symbol "MGRX".
What is Mangoceuticals's primary industry?

Company operates in the Healthcare sector and Medical - Healthcare Information Services industry.
How do i buy shares of Mangoceuticals?

Shares of Mangoceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Mangoceuticals have?

As Jul 2024, Mangoceuticals employs 3 workers, which is 50% more then previous quarter.
When Mangoceuticals went public?

Mangoceuticals, Inc. is publicly traded company for more then 2 years since IPO on 21 Mar 2023.
What is Mangoceuticals's official website?

The official website for Mangoceuticals is mangorx.com.
Where are Mangoceuticals's headquarters?

Mangoceuticals is headquartered at 15110 North Dallas Parkway, Dallas, TX.
How can i contact Mangoceuticals?

Mangoceuticals's mailing address is 15110 North Dallas Parkway, Dallas, TX and company can be reached via phone at (214) 242-9619.

Mangoceuticals, Inc.

mangorx.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Healthcare Information Services

Sector:

Healthcare

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

(214) 242-9619

15110 North Dallas Parkway
Dallas, TX 75248

CIK: 0001938046
ISIN: US56270V1061
CUSIP: 56270V106